UPHEALTH INC (UPH)

US91532B2007 - Common Stock

0.3  +0.03 (+9.13%)

Fundamental Rating

1

Overall UPH gets a fundamental rating of 1 out of 10. We evaluated UPH against 40 industry peers in the Health Care Technology industry. UPH has a bad profitability rating. Also its financial health evaluation is rather negative. UPH is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

In the past year UPH has reported negative net income.
In the past year UPH has reported a negative cash flow from operations.

1.2 Ratios

UPH's Return On Assets of -31.98% is in line compared to the rest of the industry. UPH outperforms 48.84% of its industry peers.
UPH has a Return On Equity of -117.29%. This is in the lower half of the industry: UPH underperforms 62.79% of its industry peers.
UPH has a Return On Invested Capital of 1.59%. This is amongst the best in the industry. UPH outperforms 86.05% of its industry peers.
Industry RankSector Rank
ROA -31.98%
ROE -117.29%
ROIC 1.59%
ROA(3y)-42.12%
ROA(5y)N/A
ROE(3y)-106.75%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

UPH has a Operating Margin of 0.90%. This is amongst the best in the industry. UPH outperforms 81.40% of its industry peers.
UPH has a worse Gross Margin (45.52%) than 60.47% of its industry peers.
Industry RankSector Rank
OM 0.9%
PM (TTM) N/A
GM 45.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

UPH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, UPH has more shares outstanding
Compared to 1 year ago, UPH has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -3.70, we must say that UPH is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of UPH (-3.70) is worse than 67.44% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that UPH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.03, UPH is in the better half of the industry, outperforming 69.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -3.7
ROIC/WACC0.24
WACC6.53%

2.3 Liquidity

A Current Ratio of 0.13 indicates that UPH may have some problems paying its short term obligations.
UPH has a Current ratio of 0.13. This is amonst the worse of the industry: UPH underperforms 97.67% of its industry peers.
A Quick Ratio of 0.13 indicates that UPH may have some problems paying its short term obligations.
With a Quick ratio value of 0.13, UPH is not doing good in the industry: 97.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.97% over the past year.
The Revenue has been growing slightly by 3.24% in the past year.
EPS 1Y (TTM)34.97%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q43.46%
Revenue 1Y (TTM)3.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q-15.49%

3.2 Future

Based on estimates for the next years, UPH will show a very strong growth in Earnings Per Share. The EPS will grow by 23.89% on average per year.
Based on estimates for the next years, UPH will show a decrease in Revenue. The Revenue will decrease by -0.68% on average per year.
EPS Next Y72.87%
EPS Next 2Y40.69%
EPS Next 3Y23.89%
EPS Next 5YN/A
Revenue Next Year-7.87%
Revenue Next 2Y-37.26%
Revenue Next 3Y-0.68%
Revenue Next 5YN/A

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

UPH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UPH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UPH is valued cheaply inside the industry as 90.70% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.37

4.3 Compensation for Growth

A more expensive valuation may be justified as UPH's earnings are expected to grow with 23.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.69%
EPS Next 3Y23.89%

0

5. Dividend

5.1 Amount

UPH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UPHEALTH INC

NYSE:UPH (12/11/2023, 7:20:46 PM)

0.3

+0.03 (+9.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.33M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.98%
ROE -117.29%
ROCE
ROIC
ROICexc
ROICexgc
OM 0.9%
PM (TTM) N/A
GM 45.52%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)34.97%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y72.87%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.24%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y